[1]
|
Immune Checkpoint Biology in Health and Disease
International Review of Cell and Molecular Biology,
2024
DOI:10.1016/bs.ircmb.2023.03.003
|
|
|
[2]
|
Recent advances on CAR-T signaling pave the way for prolonged persistence and new modalities in clinic
Frontiers in Immunology,
2024
DOI:10.3389/fimmu.2024.1335424
|
|
|
[3]
|
Yeast Surface Dual Display Platform for Rapid Discovery of Shark VNAR from a Semi-Synthetic Library Followed by Next-Generation Sequencing
Applied Sciences,
2023
DOI:10.3390/app132011520
|
|
|
[4]
|
“Stapling” scFv for multispecific biotherapeutics of superior properties
mAbs,
2023
DOI:10.1080/19420862.2023.2195517
|
|
|
[5]
|
Production of Plant-Derived Japanese Encephalitis Virus Multi-Epitope Peptide in Nicotiana benthamiana and Immunological Response in Mice
International Journal of Molecular Sciences,
2023
DOI:10.3390/ijms241411643
|
|
|
[6]
|
NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies
Brain,
2023
DOI:10.1093/brain/awac497
|
|
|
[7]
|
International Review of Cell and Molecular Biology,
2023
DOI:10.1016/bs.ircmb.2023.03.003
|
|
|
[8]
|
Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models
International Journal of Molecular Sciences,
2023
DOI:10.3390/ijms24087626
|
|
|
[9]
|
“Stapling” scFv for multispecific biotherapeutics of superior properties
mAbs,
2023
DOI:10.1080/19420862.2023.2195517
|
|
|
[10]
|
NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies
Brain,
2023
DOI:10.1093/brain/awac497
|
|
|
[11]
|
New Antibody Formats
International Review of Cell and Molecular Biology,
2022
DOI:10.1016/bs.ircmb.2022.03.010
|
|
|
[12]
|
Biodistribution and Activity of EGFR Targeted Polymeric Micelles Delivering a New Inhibitor of DNA Repair to Orthotopic Colorectal Cancer Xenografts with Metastasis
Molecular Pharmaceutics,
2022
DOI:10.1021/acs.molpharmaceut.1c00918
|
|
|
[13]
|
Nanobody-based CAR-T cells for cancer immunotherapy
Biomarker Research,
2022
DOI:10.1186/s40364-022-00371-7
|
|
|
[14]
|
The antigen‐binding moiety in the driver's seat of CARs
Medicinal Research Reviews,
2022
DOI:10.1002/med.21818
|
|
|
[15]
|
Biodistribution and Activity of EGFR Targeted Polymeric Micelles Delivering a New Inhibitor of DNA Repair to Orthotopic Colorectal Cancer Xenografts with Metastasis
Molecular Pharmaceutics,
2022
DOI:10.1021/acs.molpharmaceut.1c00918
|
|
|
[16]
|
New Antibody Formats
International Review of Cell and Molecular Biology,
2022
DOI:10.1016/bs.ircmb.2022.03.010
|
|
|
[17]
|
Improvement in the binding specificity of anti-isomiroestrol antibodies by expression as fragments under oxidizing conditions inside the SHuffle T7 E. coli cytoplasm
Bioscience, Biotechnology, and Biochemistry,
2022
DOI:10.1093/bbb/zbac126
|
|
|
[18]
|
Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors
Frontiers in Immunology,
2022
DOI:10.3389/fimmu.2022.1005800
|
|
|
[19]
|
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Journal of Hematology & Oncology,
2022
DOI:10.1186/s13045-022-01382-5
|
|
|
[20]
|
A 33-residue peptide tag increases solubility and stability of Escherichia coli produced single-chain antibody fragments
Nature Communications,
2022
DOI:10.1038/s41467-022-32423-9
|
|
|
[21]
|
Novel modular chimeric antigen receptor spacer for T cells derived from signal regulatory protein alpha Ig-like domains
Frontiers in Molecular Medicine,
2022
DOI:10.3389/fmmed.2022.1049580
|
|
|
[22]
|
Novel modular chimeric antigen receptor spacer for T cells derived from signal regulatory protein alpha Ig-like domains
Frontiers in Molecular Medicine,
2022
DOI:10.3389/fmmed.2022.1049580
|
|
|
[23]
|
Advances in Clinical Chemistry,
2021
DOI:10.1016/bs.acc.2020.09.001
|
|
|
[24]
|
Advances in Clinical Chemistry,
2021
DOI:10.1016/bs.acc.2020.09.001
|
|
|
[25]
|
Autoinduction as Means for Optimization of the Heterologous Expression of Recombinant Single-Chain Fv (scFv) Antibodies
Molecular Biotechnology,
2021
DOI:10.1007/s12033-021-00363-2
|
|
|
[26]
|
Machine Learning Feature Selection for Predicting High Concentration Therapeutic Antibody Aggregation
Journal of Pharmaceutical Sciences,
2021
DOI:10.1016/j.xphs.2020.12.014
|
|
|
[27]
|
The Application of Nanobody in CAR-T Therapy
Biomolecules,
2021
DOI:10.3390/biom11020238
|
|
|
[28]
|
CAR-NK Cells in the Treatment of Solid Tumors
International Journal of Molecular Sciences,
2021
DOI:10.3390/ijms22115899
|
|
|
[29]
|
Driving CARs with alternative navigation tools – the potential of engineered binding scaffolds
The FEBS Journal,
2021
DOI:10.1111/febs.15523
|
|
|
[30]
|
Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing
Cells,
2021
DOI:10.3390/cells11010021
|
|
|
[31]
|
Chaperone and Immunoglobulin-Binding Activities of Skp Protein from Yersinia pseudotuberculosis
Biochemistry (Moscow),
2020
DOI:10.1134/S0006297920010071
|
|
|
[32]
|
CAR-T design: Elements and their synergistic function
EBioMedicine,
2020
DOI:10.1016/j.ebiom.2020.102931
|
|
|
[33]
|
Driving CARs with alternative navigation tools – the potential of engineered binding scaffolds
The FEBS Journal,
2020
DOI:10.1111/febs.15523
|
|
|
[34]
|
Live long and active: Polypeptide-mediated assembly of antibody variable fragments
Advanced Drug Delivery Reviews,
2020
DOI:10.1016/j.addr.2020.10.017
|
|
|
[35]
|
Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation
Blood Advances,
2020
DOI:10.1182/bloodadvances.2020002255
|
|
|
[36]
|
Autoimmune encephalitis: novel therapeutic targets at the preclinical level
Expert Opinion on Therapeutic Targets,
2020
DOI:10.1080/14728222.2021.1856370
|
|
|
[37]
|
Protection of Alcohol Dehydrogenase against Freeze–Thaw Stress by Ice-Binding Proteins Is Proportional to Their Ice Recrystallization Inhibition Property
Marine Drugs,
2020
DOI:10.3390/md18120638
|
|
|
[38]
|
Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody Fragments
Cancer Immunology Research,
2020
DOI:10.1158/2326-6066.CIR-19-0734
|
|
|
[39]
|
Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 Complex
Journal of Molecular Biology,
2019
DOI:10.1016/j.jmb.2019.10.022
|
|
|
[40]
|
Improving the Developability of an Antigen Binding Fragment by Aspartate Substitutions
Biochemistry,
2019
DOI:10.1021/acs.biochem.9b00251
|
|
|
[41]
|
Ice-recrystallization inhibiting polymers protect proteins against freeze-stress and enable glycerol-free cryostorage
Materials Horizons,
2019
DOI:10.1039/C8MH00727F
|
|
|
[42]
|
Amino acid induced hyper activation of laccase and its application in dye degradation
Biocatalysis and Agricultural Biotechnology,
2019
DOI:10.1016/j.bcab.2019.101064
|
|
|
[43]
|
Chimeric Antigen Receptors Incorporating D Domains Targeting CD123 Direct Potent Mono- and Bi-specific Antitumor Activity of T Cells
Molecular Therapy,
2019
DOI:10.1016/j.ymthe.2019.04.010
|
|
|
[44]
|
Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development
mAbs,
2019
DOI:10.1080/19420862.2019.1660564
|
|
|
[45]
|
Design and Production of Bispecific Antibodies
Antibodies,
2019
DOI:10.3390/antib8030043
|
|
|
[46]
|
Improving the Developability of an Antigen Binding Fragment by Aspartate Substitutions
Biochemistry,
2019
DOI:10.1021/acs.biochem.9b00251
|
|
|
[47]
|
Expression of a functional intrabody against hepatitis C virus core protein in Escherichia coli and silkworm pupae
Protein Expression and Purification,
2018
DOI:10.1016/j.pep.2018.05.009
|
|
|
[48]
|
Challenges in Protein Product Development
AAPS Advances in the Pharmaceutical Sciences Series,
2018
DOI:10.1007/978-3-319-90603-4_22
|
|
|
[49]
|
Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells
mAbs,
2018
DOI:10.1080/19420862.2018.1494105
|
|
|
[50]
|
Strategies to Address Chimeric Antigen Receptor Tonic Signaling
Molecular Cancer Therapeutics,
2018
DOI:10.1158/1535-7163.MCT-17-1097
|
|
|
[51]
|
Optimizing antibody expression: The nuts and bolts
Methods,
2017
DOI:10.1016/j.ymeth.2017.01.009
|
|
|
[52]
|
Development of humanized scFv antibody fragment(s) that targets and blocks specific HLA alleles linked to myasthenia gravis
Applied Microbiology and Biotechnology,
2017
DOI:10.1007/s00253-017-8557-1
|
|
|
[53]
|
Antibody Aggregation: Insights from Sequence and Structure
Antibodies,
2016
DOI:10.3390/antib5030019
|
|
|
[54]
|
Molecular Effects of Concentrated Solutes on Protein Hydration, Dynamics, and Electrostatics
Biophysical Journal,
2016
DOI:10.1016/j.bpj.2016.07.011
|
|
|
[55]
|
Testing the anti-fibrotic potential of the single-chain Fv antibody against theα2 C-terminal telopeptide of collagen I
Connective Tissue Research,
2014
DOI:10.3109/03008207.2013.862528
|
|
|